Potassium Chloride Extended-Release Capsules
CGMP Deviations
354 recalls, newest first
CGMP Deviations
CGMP Deviations
Failed Dissolution Specifications
Failed Dissolution Specifications
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Defective Container
Defective Container
Defective Container
CGMP Deviations
Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Lack of Assurance of Sterility: Leaking vials
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Discoloration: Brownish tablets
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Failed Impurities/Degradation Specifications.
Failed Impurities/Degradation Specifications.
Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility